title: Exencephaly induction by valproic acid in the genetic polydactyly/arhinencephaly mouse, Pdn/Pdn.
abstract: Non-treated homozygous polydactyly/arhinencephaly (Pdn/Pdn) mouse fetuses exhibited exencephaly in 16.7% of cases. Treatment of Pdn/Pdn mice with 350 mg/kg of valproic acid (VPA) on days 8.5 and 9.5 of gestation increased the rate of exencephaly to 66.7%. The responsible gene for the Pdn mouse phenotype has been determined to be Gli3, and the suppression of Gli3 gene expression has been documented in Pdn/Pdn embryos. We investigated how the sonic hedgehog (Shh) and Fgf8 genes, the correlated genes of Gli3, are expressed in the VPA-treated exencephalic Pdn/Pdn embryos on day 10 of gestation, using whole mount in situ hybridization (WISH) and real-time PCR methods. We could not detect any alterations in Shh expression by real-time PCR, or WISH in the non-treated Pdn/Pdn and VPA-treated exencephalic Pdn/Pdn embryos. Altered Fgf8 expression patterns were observed in the commissural plate and dorsal isthmal neuroepithelium in the non-treated Pdn/Pdn embryos. We speculated that the altered expression of Fgf8 might be the result of down-regulation of Gli3 in Pdn/Pdn embryos. Fgf8 gene expression in the commissural plate and dorsal isthmal neuroepithelium exhibits wide or altered signal patterns in the VPA-treated exencephalic Pdn/Pdn embryo. From these findings, it was suggested that down-regulation of Gli3 gene expression induced the altered expression of Fgf8 in the Pdn/Pdn embryos, and that VPA treatment accelerated the alterations of Fgf8 gene expression in the Pdn/Pdn embryos. It was further speculated that altered expression of Fgf8 in the commissural plate may be the fundamental cause of exencephaly, and that the synergistic effect between gene and drug shown in this experiment may explain the differences of sensitivity in the side-effects of the drug.
authors.affiliation: School of Health Science, Faculty of Medicine, Tottori University, Yonago, Japan.
authors.forename: Mizuho
authors.initials: M
authors.lastname: Maekawa
authors.forename: Ken-Ichi
authors.initials: K
authors.lastname: Ohta
authors.forename: Ryu-Ichi
authors.initials: R
authors.lastname: Katagiri
authors.forename: Etsuko
authors.initials: E
authors.lastname: Ueta
authors.forename: Ichiro
authors.initials: I
authors.lastname: Naruse
mesh_terms: D000015:Abnormalities, Multiple / Q000139:chemically induced / Q000235:genetics; D000818:Animals; D019465:Craniofacial Abnormalities / Q000235:genetics; D015536:Down-Regulation; D051524:Fibroblast Growth Factor 8 / Q000235:genetics / Q000378:metabolism; D018507:Gene Expression Regulation, Developmental; D053823:Hedgehog Proteins; D051741:Kruppel-Like Transcription Factors / Q000235:genetics*; D051379:Mice; D008817:Mice, Mutant Strains; D009419:Nerve Tissue Proteins / Q000235:genetics*; D009436:Neural Tube Defects / Q000139:chemically induced* / Q000235:genetics*; D017689:Polydactyly / Q000139:chemically induced / Q000235:genetics; D013577:Syndrome; D015534:Trans-Activators / Q000235:genetics / Q000378:metabolism; D014635:Valproic Acid / Q000633:toxicity; D000074290:Zinc Finger Protein Gli3
chemical_list: C496457:Fgf8 protein, mouse; C465571:Gli3 protein, mouse; D053823:Hedgehog Proteins; D051741:Kruppel-Like Transcription Factors; D009419:Nerve Tissue Proteins; C465570:Shh protein, mouse; D015534:Trans-Activators; D000074290:Zinc Finger Protein Gli3; D051524:Fibroblast Growth Factor 8; D014635:Valproic Acid